Correlation of MCP-4 and high-sensitivity C-reactive protein as a marker of inflammation in obesity and chronic periodontitis

Cytokine

Volumn 61, Issue 3, 2013, Pages 772-777

  Pradeep, A R ^a   Kumari, Minal ^a   Kalra, Nitish ^a   Priyanka, N ^a  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

C reactive protein; Chronic periodontitis; Monocyte chemoattractant protein; Obesity

Indexed keywords

C REACTIVE PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; INFLAMMATION; MALE; MOLECULAR PATHOLOGY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TURBIDIMETRY;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHRONIC PERIODONTITIS; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MONOCYTE CHEMOATTRACTANT PROTEINS; OBESITY; PERIODONTAL INDEX;

EID: 84875373856     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.12.022     Document Type: Article

References (43)

1. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
2. Ritchie C.S. Obesity and periodontal disease. Periodontol 2000 2007, 44:154-163.
3. Dahiya P., Kamal R., Gupta R. Obesity, periodontal and general health: Relationship and management. Indian J Endocrinol Metab 2012, 16:88-93.
4. Nishida N., Tanaka M., Hayashi N., Nagata H., Takeshita T., Nakayama K., et al. Determination of smoking and obesity as periodontitis risks using the classification and regression tree method. J Periodontol 2005, 76:923-928.
5. Holt S.C., Ebersole J.L. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the 'red complex', a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 2005, 38:72-122.
6. Pischon N., Heng N., Bernimoulin J.P., Kleber B.M., Willich S.N., Pischon T. Obesity, inflammation, and periodontal disease. J Dent Res 2007, 86:400-409.
7. Silva T.A., Garlet G.P., Fukada S.Y., Silva J.S., Cunha F.Q. Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 2007, 86:306-319.
8. Pype J.L., Dupont L.J., Menten P., et al. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol 1999, 21:528-536.
9. Dezerega A., Pozo P., Hernández M., et al. Chemokine monocyte chemoattractant protein-3 in progressive periodontal lesions in patients with chronic periodontitis. J Periodontol 2010, 81:267-276.
10. Garcia-Zepeda E.A., Combadiere C., Rothenberg M.E., et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and non-allergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 1996, 157:5613-5626.
11. Hashimoto I., Wada J., Hida A., et al. Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects. Obesity (Silver Spring) 2006, 14:799-811.
12. Iwamoto T., Okamoto H., Iikuni N., et al. Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:421-424.
13. Breland U.M., Michelsen A.E., Skjelland M., et al. Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. Cardiovasc Res 2010, 86:265-273.
14. Lamkhioued B., Garcia-Zepeda E.A., Abi-Younes S., et al. Monocyte chemoattractant protein (MCP)-4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines. Am J Respir Crit Care Med 2000, 162(2 Pt 1):723-732.
15. Chakravorty S.J., Howie A.J., Girdlestone J., Gentle D., Savage C.O. Potential role for monocyte chemotactic protein-4 (MCP-4) in monocyte/macrophage recruitment in acute renal inflammation. J Pathol 2001, 194:239-246.
16. Kurtis B., Tuter G., Serdar M., Akdemir P., Uygur C., Firatli E., et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor - alpha in patients with chronic and aggressive periodontitis. J Periodontol 2005, 76:1849-1855.
17. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003, 12:1785-1788.
18. Ebersole J.L., Cappelli D. Acute phase reaction in infection and inflammatory diseases. Periodontol 2000 1984, 23:19-49.
19. Megson E., Fitzsimmons T., Dharmapatni K., Mark Bartold P. C-reactive protein in gingival crevicular fluid may be indicative of systemic inflammation. J Clin Periodontol 2010, 37:797-804.
20. Paraskevas S., Huizinga J.D., Loos B.G. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008, 35:277-290.
21. Buhlin K., Guastafssoon A., Pockley A.G., Frostegard J., Klinge B. Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J 2003, 24:2099-2107.
22. Noack B., Genco R.J., Trevisan M., Grossi S., Zambon J.J., De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001, 72:1221-1227.
23. Das U.N. Is obesity an inflammatory condition?. Nutrition 2001, 17:953-966.
24. Maachi M., Pieroni L., Bruckert E., et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNF alpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004, 28:993-997.
25. Dasu M.R., Devaraj S., Du Clos T.W., Jialal I. The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells. J Lipid Res 2007, 48:509-512.
26. WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163.
27. Loe H., Holm-Pedersen P. Absence and presence of fluid from normal and inflamed gingivae. Periodontics 1965, 149:171-177.
28. Genco R.J., Grossi S.G., Ho A., Nishimura F., Murayama Y. A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol 2005, 76(11 Suppl):2075-2084.
29. Kim C.S., Park H.S., Kawada T., et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity related parameters. Int J Obes 2006, 30:1347-1355.
30. Al-Zahrani M.S., Borawski E.A., Bissada N.F. Increased physical activity reduces prevalence of periodontitis. J Dent 2005, 33:703-710.
31. Christiansen T., Richelsen B., Bruun J.M. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes Relat Metab Disord 2005, 29:146-150.
32. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001, 250:91-104.
33. Dahlman I., Kaaman M., Olsson, et al. A Unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 2005, 90:5834-5840.
34. Baker P.J. The role of immune responses in bone loss during periodontal disease. Microbes Infect 2000, 2:1181-1192.
35. Pradeep A.R., Daisy H., Hadge P. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in periodontal health and disease. Arch Oral Biol 2009, 54:503-509.
36. Petering H., Höchstetter R., Kimmig D., Smolarski R., Kapp A., Elsner J. Detection of MCP-4 in dermal fibroblasts and its activation of the respiratory burst in human eosinophils. J Immunol 1998, 15(160):555-558.
37. Perlstein M.I., Bissada N.F. Influence of obesity and hypertension on the severity of periodontitis in rats. Oral Surg Oral Med Oral Pathol 1977, 43:707-719.
38. Amar S., Zhou Q., Shaik-Dasthagirisaheb Y., Leeman S. Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci 2007, 104:20466-20471.
39. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131-2135.
40. Forouhi N.G., Sattar N., McKeigue P.M. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001, 25:1327-1331.
41. Devaraj S., Kumaresan P.R., Jialal I. Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J Mol Cell Cardiol 2004, 36:405-410.
42. Blake G.J., Ridker P.M. High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis. Eur Heart J 2001, 22:349-352.
43. Craig R.G., Yip J.K., So M.K., Boylan R.J., Socransky S.S., Haffajee A.D. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 2003, 74:1007-1016.